Life-changing treatments at affordable prices': Hyd-based DFE Pharma launches `C2F' for robust formulations

With the C2F center, DFE Pharma aims to support global and local pharmaceutical and nutraceutical companies to address these challenges, by developing robust formulations allowing for scale-up, high-speed production, and first-to-market launch.

By Newsmeter Network  Published on  13 Sep 2022 11:12 AM GMT
Life-changing treatments at affordable prices: Hyd-based DFE Pharma launches `C2F for robust formulations

Hyderabad-based DFE Pharma has launched `Closer to the Formulator' (C2F), a Center of Excellence in Hyderabad, to shorten the time from concept to finished commercial product through its expertise in pharmaceutical development.

Minister for IT, Industries & Commerce, Municipal Administration & Urban Department K.T. Rama Rao along with Jayesh Ranjan, Principal Secretary, Industries and Commerce, integrated the facility. Others who were present include. Shakthi Nagappan, Director (Life Sciences & Pharma), Government of Telangana and DFE Pharma's leadership team and senior representatives of leading pharmaceutical companies.

The pharmaceutical industry has undergone a rapid transformation in recent years with growing competition, and more pressure to provide life-changing treatments at affordable prices. The pandemic created an increased demand for medicines and local manufacturing.

With the C2F center, DFE Pharma aims to support global and local pharmaceutical and nutraceutical companies to address these challenges, by developing robust formulations allowing for scale-up, high-speed production, and first-to-market launch.

The cutting-edge 1200 sq meters laboratory facilities of the C2F center are equipped with the latest technology and staffed by highly experienced scientists. The C2F center is based in Genome Valley, Hyderabad, the largest pharma and life sciences hub in Asia; a privileged location, with many major Indian and global (bio)pharmaceutical companies, as well as worldwide renowned research institutions. This vibrant R&D cluster drives collaboration and innovation among some of the global key players in the pharmaceutical industry.

The services offered by this new center, mainly focus on oral solid dosage (OSD) forms and comprise a range of pre-registration work including development, scale-up, and technology transfer. The capabilities also include efficiency projects like conversions from wet granulation to direct compression. The center works with active pharmaceutical ingredients (APIs) with a broad portfolio of all categories of excipients and their different grades.

"I'm delighted to inaugurate Closer to the Formulator (C2F), a Center of Excellence by DFE Pharma in Hyderabad. I firmly believe that C2F will further strengthen the potential for growth and support offered by Genome Valley. The Government of Telangana will work with DFE Pharma to ensure that Life Sciences companies in the state leverage from this facility," KTR said.

Speaking about C2F, Martti Hedman, CEO of DFE Pharma added: "With our C2F center, based at a prime location in the pharma and life sciences hub Genome Valley, we can help pharmaceutical and nutraceutical companies progress their projects faster and further. Through our capabilities, we not only support our customers to develop high-quality products but also improve their efficiencies. We feel privileged by the support we are receiving from the Telangana government to do so."

"We aim to closely work with our customers to help them develop new ideas. Together we address their challenges using our expertise in the latest pharmaceutical trends" explained Dr. Anilkumar Gandhi, Director of the C2F Center of Excellence.

"The capabilities offered through this center can reduce the time to launch a product, without compromising quality, while reducing the number of development assays and therefore decreasing formulation spending," he added.

Next Story
Share it